Effects of citicholine in subcortical dementia associated with Parkinson's disease assessed by quantified electroencephalography

García-Mas, A.; Rossiñol, A.; Roca, M.; Lozano, R.; Rosselló, J.; Llinas, J.

Clinical Therapeutics 14(5): 718-729

1992


ISSN/ISBN: 0149-2918
PMID: 1468090
Document Number: 948
Two groups of patients with idiopathic Parkinson's disease underwent quantified electroencephalography (EEGq) using fast Fourier transfer to assess the effects of treatment with citicholine. Evidence of cortical cognitive impairment was seen in one group but not in the other. Certain parameters were established which enabled the two groups to be distinguished by examining specific EEGq indices. Specifically, differences were found in the overall potentials of the delta and alpha bands, in the alpha/theta index, in posterior activity, in the anteriorization index of the delta and alpha rhythms, and in the spatialization index of the alpha rhythm. The implications of these differences in the potential involvement of the frontal lobes in subcortical dementia in Parkinson's disease are discussed.

Document emailed within 1 workday
Secure & encrypted payments

Effects of citicholine in subcortical dementia associated with Parkinson's disease assessed by quantified electroencephalography